Showing results (41-50 of 81) with videos related to
Sort By:
Pageof 9
Documenta Ophthalmologica. Advances in Ophthalmology|April 7, 2017
Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathyFred K Chen, Avenell L Chew, Dan Zhang, et al.Biomedicines|December 23, 2023
Recent Therapeutic Progress and Future Perspectives for the Treatment of Hearing LossJoey Lye, Derek S Delaney, Fiona K Leith, et al.Stem Cell Research|August 10, 2018
Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutationXiao Zhang, Dan Zhang, Shang-Chih Chen, et al.Documenta Ophthalmologica. Advances in Ophthalmology|April 9, 2026
Autosomal dominant Riggs-type congenital stationary night blindness with fundus sheen and retinal atrophy due to a novel GNAT1 p.Gln200Arg variantJeremy J Chou, Rachael C Heath Jeffery, Jennifer A Thompson, et al.Stem Cell Research|January 6, 2019
Generation of two induced pluripotent stem cell lines from a patient with dominant PRPF31 mutation and a related non-penetrant carrierSamuel McLenachan, Dan Zhang, Xiao Zhang, et al.Molecular Pharmaceutics|June 20, 2024
Polymer-Based Nanoparticles with Probucol and Lithocholic Acid: A Novel Therapeutic Approach for Oxidative Stress-Induced RetinopathiesSusbin Raj Wagle, Bozica Kovacevic, Corina Mihaela Ionescu, et al.Stem Cell Research|May 7, 2019
Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutationXiao Zhang, Sang Yoon Moon, Dan Zhang, et al.Fibrogenesis & Tissue Repair|May 19, 2015
Prospects for clinical use of reprogrammed cells for autologous treatment of macular degenerationAna Belen Alvarez Palomo, Samuel McLenachan, Fred K Chen, et al.Stem Cell Research|August 19, 2020
Generation of two induced pluripotent stem cell lines from a patient with Stargardt Macular Dystrophy caused by the c.768G>T and c.6079C>T mutations in ABCA4Luke Jennings, Dan Zhang, Shang-Chih Chen, et al.Translational Vision Science & Technology|July 9, 2026
Characterization of Rcbtb1 Knockout Mice and Evaluation of AAV2-RCBTB1 Gene Replacement TherapySamuel McLenachan, Rabab Rashwan, Zhiqin Huang, et al.Pageof 9